Global Head, Medicinal & Biologics Team
BSI Group
Theresa Jeary, Global Head, Medicinal & Biologics Team, BSI.
Theresa has a MSc in Pharmaceutical Science and over 30 years’ experience in the Pharmaceutical and Medical Device sectors.
In addition to product development and regulatory expertise from a industry perspective,
Theresa has 15 years Notified Body experience and was recently appointed the Global Head of the Medicinal & Biologics Team at BSI, leading a multidisciplinary team, of experts with responsibility for the A117 service offering, Conformity assessment processes for devices that utilise human or animal tissue, Rule 21, IVF/ ART, Preservation Solutions for Organ transplantation, Rule 14 Device medicinal consultations and consultations for devices utilising TSE risk species tissues as per 722/2012.
Theresa is a regular presenter on MDR Implementation, Rule 14 and Article 117 and regularly participates in Team-NB working groups, heading the Rule 21 WG, and contributes to various scientific publications and regulatory guidance and has extensive experience of interacting with EU Competent Authorities.
Disclosure information not submitted.
Tuesday, May 7, 2024
15:05 – 16:05 CEST